Month: April 2023

Rapid Growth Expected in the Medical Fiber Optics Market Amidst Rising Demand for Efficient and Accurate Medical Diagnosis

Written by Customer Service on April 12, 2023. Posted in Mergers And Acquisitions.

SkyQuest’s Medical Fiber Optics market report is an excellent analysis for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford USA, April 12, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the Medical Fiber Optics market will attain a value of USD 71.10 billion by 2030, with a CAGR of 5.4% over the forecast (2022-2030). The usage of lasers in dentistry and cosmetology is predicted to fuel market expansion due to better...

Xtract One Technologies Announces Shareholders Approval and Closing of Final Tranche of C$13.4M Investment by Madison Square Garden Sports

Written by Customer Service on April 12, 2023. Posted in Public Companies.

Xtract One Technologies Announces Shareholders Approval and Closing of Final Tranche of C$13.4M Investment by Madison Square Garden Sports Xtract One Technologies Announces Shareholders Approval and Closing of Final Tranche of C$13.4M Investment by Madison Square Garden SportsTORONTO, April 12, 2023 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA)(OTCQX: XTRAF)(FRA:0PL) (“Xtract One” or the “Company”) today announced that, at the extraordinary meeting of shareholders held on April 11, 2023 (the “Meeting”), Xtract One’s shareholders approved the sale and issuance of 11,925,595 units (the “Units”) at a price of C$0.42 per Unit to MSG Sports Ventures, LLC (“MSGSV”), an indirect wholly-owned subsidiary of Madison Square Garden Sports Corp. (“MSG Sports”), which sale constitutes the second tranche (the “Second Tranche”)...

Unaudited consolidated interim accounts for the first quarter of 2023

Written by Customer Service on April 12, 2023. Posted in Earnings Releases And Operating Results.

Segments (EURm) Q1/23 Q1/22 yoySelver supermarkets 147.2 139.5 5.5%Department stores 24.7 21.7 14.1%Car trade 41.7 34.0 22.7%Security segment 2.9 2.3 25.6%Real Estate 1.6 1.5 6.0%Total sales 218.1 198.9 9.6% Selver supermarkets 1.7 2.3 -26.0%Department stores -0.8 -1.7 -54.3%Car trade 3.0 2.1 42.1%Security segment 0.1 0.0 –Real Estate 2.5 2.6 -6.3%IFRS 16 -0.5 -0.4 20.8%Total profit before tax 5.9 4.9 20.5%In the first quarter of 2023, the consolidated unaudited sales revenue of the Group was 218.1 million euros. Compared to the first quarter of 2022, the growth was 9.6%. The net profit for the reporting period was 0.6 million euros, which increased by 43.2% compared to the first quarter of 2022, including income tax of 5.3 million euros (4.5 million euros in 2022). The pre-tax...

RomReal Notice and Proxy Form AGM 2022 on 27 April 2023

Written by Customer Service on April 12, 2023. Posted in Public Companies.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsAGM Notice 04 2023Proxyform AGM 04 2023

Changes in composition of the Audit Committee and Remuneration Committee

Written by Customer Service on April 12, 2023. Posted in Public Companies.

The Supervisory Board of Coop Pank AS recalled Alo Ivask from the Audit Committee. The Supervisory Board elected Rainer Rohtla to be a new member to the Audit Committee effective from 12.04.2023. The current Audit Committee members, Veikko Haavapuu, Silver Kuus and Stan Nahkor, will continue in the Audit Committee. Changes also took place in the Remuneration Committee. Alo Ivask was recalled from the Remuneration Committee. The Supervisory Board elected Rainer Rohtla to be a new member to the Remuneration Committee effective from 12.04.2023. The current Remuneration Committee members, Jaan Marjundi, Raul Parusk and Irja Rae will continue in the Remuneration Committee. Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The number of clients using Coop Pank for their daily banking reached 152,200....

Henrik Ehrnrooth elected to chair the Board of Directors of UPM-Kymmene Corporation

Written by Customer Service on April 12, 2023. Posted in Public Companies.

UPM-Kymmene Corporation Stock Exchange Release (Other information disclosed according to the rules of the Exchange) 12 April 2023 at 17:00 EEST Henrik Ehrnrooth elected to chair the Board of Directors of UPM-Kymmene Corporation Henrik Ehrnrooth was elected as Chair, and Kim Wahl as Deputy Chair of the Board of Directors of UPM-Kymmene Corporation at the Board of Directors’ constitutive meeting that took place today following the Annual General Meeting. In addition, the Board of Directors elected the chairs and other members to the Board committees from among its members:Kim Wahl was re-elected to chair the Audit Committee, and Pia Aaltonen-Forsell and Marjan Oudeman were elected as other committee members. Martin à Porta was re-elected to chair the Remuneration Committee, and Emma FitzGerald and Topi Manner were elected...

Form 8.3 – [EMIS Group plc – 11 04 2023] – (CGWL)

Written by Customer Service on April 12, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree EMIS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Hydrocolloids Market is Expected to Grow $14.5 billion by 2028 – Exclusive Report by MarketsandMarkets™

Written by Customer Service on April 12, 2023. Posted in Mergers And Acquisitions.

The exponential growth in the natural and clean-label food consumption across the food and beverage industry due to its growing awareness has influenced the use of hydrocolloids. Chicago, April 12, 2023 (GLOBE NEWSWIRE) — According to MarketsandMarkets™, The global hydrocolloids market is estimated to be valued at USD 11.2 Billion in 2023. It is projected to reach USD 14.5 billion by 2028, recording a CAGR of 5.4% during the forecast period. The exponential growth in natural and clean-label food consumption across the food and beverage industry due to its growing awareness has influenced the use of hydrocolloids. Moreover, this has led to an increase in dependence on natural fibers and gums for functional properties, stability, safety, and quality of food products. Furthermore, hydrocolloid manufacturing companies follow...

Bloomage Biotech reports 28.53% YoY revenue increase, reaches $927.8 million in 2022

Written by Customer Service on April 12, 2023. Posted in Earnings Releases And Operating Results.

Bloomage Biotech 2022 Financial Report Bloomage Biotech reports 28.53% YoY revenue increase, reaches $927.8 million in 2022Parsippany, New Jersey, USA, April 12, 2023 (GLOBE NEWSWIRE) — Bloomage Biotech (688363.SH) released its 2022 Financial Report on March 30, 2023, posting a revenue of $924 million, an increase of 28.53% year-over-year (YoY). The net profit attributable to the owners of the parent company was $151 million, an increase of 24.11% YoY, and the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was $133 million, an increase of 28.46% YoY. During the reporting period, all four business segments of Bloomage Biotech experienced overall revenue growth and enhanced profitability due to increased scale. According to the annual report, the company’s raw materials...

Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights

Written by Customer Service on April 12, 2023. Posted in Earnings Releases And Operating Results.

– 2022 marks Ceapro’s best performance in Company history with record sales of $18,800,000 compared to $17,200,000 for 2021, representing a 10% increase year over year – Net profit after tax of $4,400,000 for the full year of 2022 compared to $3,400,000 in 2021, a year over year increase of 31% – R&D activities focused on advancement toward avenanthramide Phase 1-2a clinical study, development of innovative delivery systems with new chemical complexes and processing yeast beta glucan for development as an immune booster and potential inhalable therapeutic for lung fibrotic diseases – Continued execution on strategic plans position Ceapro for a transformational year in 2023 EDMONTON, Alberta, April 12, 2023 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company...

Month: April 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals